We are live on ! Find out more
CYCN icon

Cyclerion Therapeutics
CYCN

40 hedge funds and large institutions have $13.7M invested in Cyclerion Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,250% more call options, than puts

Call options by funds: $307K | Put options by funds: $2K

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

8% more funds holding

Funds holding: 37 → 40 (+3)

0.05% less ownership

Funds ownership: 2.44% → 2.39% (-0.05%)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

25% less capital invested

Capital invested by funds: $18.3M → $13.7M (-$4.6M)

Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
8
Closed
5
Calls
$307K
Puts
$2K
Net Calls
+$305K
Net Calls Change
-$96K

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$28.7K
2
Jane Street
Jane Street
New York
+$15.1K
3
UBS Group
UBS Group
Switzerland
+$10.8K
4
TRCT
Tower Research Capital (TRC)
New York
+$4.45K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.2K

Top Sellers

Rank Fund Capital Flow
1
DC
Diametric Capital
Massachusetts
-$210K
2
PCM
Prelude Capital Management
New York
-$80K
3
Renaissance Technologies
Renaissance Technologies
New York
-$59K
4
TSS
Two Sigma Securities
New York
-$17K
5
Verition Fund Management
Verition Fund Management
Connecticut
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$2.16K -$71 -6 -4%
Wells Fargo
27
Wells Fargo
California
$1.55K +$1.18K +100 +556%
SWM
28
Spire Wealth Management
Virginia
$1K +$639 +54 New
Simplex Trading
29
Simplex Trading
Illinois
$1K +$674 +57 +163%
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$208 – – –
CYG
31
Clean Yield Group
Vermont
$75 – – –
Bank of America
32
Bank of America
North Carolina
$31 +$24 +2 New
Northwestern Mutual Wealth Management
33
Northwestern Mutual Wealth Management
Wisconsin
$18 – – –
CA
34
Corrado Advisors
New Jersey
$13 +$12 +1 New
TF
35
TimeScale Financial
Massachusetts
$9 – – –
ASN
36
Advisory Services Network
Georgia
$7 +$12 +1 New
CWP
37
Concord Wealth Partners
Virginia
$7 +$12 +1 New
DC
38
Diametric Capital
Massachusetts
– -$210K -12,186 Closed
PCM
39
Prelude Capital Management
New York
– -$80K -4,627 Closed
TSS
40
Two Sigma Securities
New York
– -$17K -1,012 Closed
Verition Fund Management
41
Verition Fund Management
Connecticut
– -$17K -1,000 Closed
Citadel Advisors
42
Citadel Advisors
Florida
– -$6.3K -533 Closed
1
2

CYCN Hedge Fund Activity: Q4 2022 in Review

40 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cyclerion Therapeutics (CYCN) for Q4 2022, worth a combined $13.7M — down 25% from $18.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CYCN positions and 5 closed out — a net gain of 3 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $28.7K. The largest seller was Diametric Capital, exiting entirely with an estimated $210K sold.

  • 40 institutional investors held Cyclerion Therapeutics (CYCN) as of Q4 2022, up from 37 in Q3 2022.
  • Funds reported $13.7M of Cyclerion Therapeutics stock for Q4 2022, down 25% quarter-over-quarter.
  • 8 funds opened new Cyclerion Therapeutics positions in Q4 2022 and 5 closed out, a net change of +3 holders.
  • The largest Cyclerion Therapeutics buyer in Q4 2022 was Virtu Financial, an estimated $28.7K added.
  • The largest Cyclerion Therapeutics seller in Q4 2022 was Diametric Capital, an estimated $210K sold.

Based on aggregated 13F filings for Q4 2022.